SYMPATH Symposium on targeting synucleinopathies

The SYMPATH Symposium on targeting synucleinopathies will bring together world-leading experts to
discuss recent progress in developing therapeutic vaccines targeting PD and MSA. The programme
includes pathogenesis, biomarkers and clinical challenges in PD and MSA.

Confirmed Speakers include
• Omar El-Agnaf, Hamid Bin Khalifa University, Qatar
• Kuldip Dave, Michael J. Fox Foundation, USA
• Joaquim Ferreira, University of Lisbon, Portugal
• Gergana Galabova, AFFiRiS AG, Austria
• Kenneth Marek, Yale University, USA
• Eliezer Masliah, UC San Diego, USA
• Wassilios Meissner, University Hospital Bordeaux, France
• Werner Poewe, Medical University Innsbruck, Austria
• Dieter Volc, Prosenex Ambulatorium BetriebsgesmbH, Austria
• Dieter Willbold, Forschungszentrum Jülich GmbH, Germany

Share this...

Facebook

Twitter

Linkedin